Pfizer
Pfizer to invest $200m in Irish biomanufacturing plant
September 21, 2011Manufacturing and Production Ireland, Pfizer, pharma manufacturing news
Pfizer is planning to invest around €145 million ($200m) at its biomanufacturing facility in Co Dublin, Ireland, according to the …
Ex-Pfizer employees set up new business at Sandwich
September 1, 2011Research and Development Pfizer, Sandwich, The Research Network, research and development news
Seven former Pfizer employees have set up a new business in Sandwich that will provide outsourcing services for the pharma …
FDA approves Pfizer’s lung cancer drug Xalkori
August 30, 2011Sales and Marketing FDA, Pfizer, Xalkori, crizotinib
Pfizer’s lung cancer drug Xalkori has been approved by the FDA, a month ahead of schedule. Xalkori (crizotinib) is now …
EMA to review two new Pfizer cancer drugs
August 19, 2011Sales and Marketing Cancer, Pfizer, bosutinib, crizotinib
The EMA has accepted Pfizer’s regulatory submissions for two of its new cancer compounds. The first is its much-lauded crizotinib, …
Pfizer triumphs in US Viagra patent trial
August 17, 2011Sales and Marketing Pfizer, generics, viagra
Pfizer has won a US patent infringement case against generics giant Teva, stopping the company from making its own version …
Online learning for non-medical prescribers launched
August 12, 2011Medical Communications Pfizer, Prescriber, medical education, non medical prescribing
Therapeutics PLUS, a free online medical education offering to healthcare professionals has been re-launched. The online resource has been created …
Pfizer pays compensation to Nigerian trial victims
August 12, 2011Kano, Pfizer, Trovan, misconduct, out of court
Pfizer has paid out the first compensation to families of children who died during a meningitis drug trial in Nigeria. …
Pfizer teams up with University of California for drug discovery
August 9, 2011Research and Development, Sales and Marketing Pfizer, academic research
Pfizer has signed a deal with the University of California to help expand its drug discovery and development programme. The …
Mergers and spending cuts damaging drug research
August 3, 2011Research and Development, Sales and Marketing LaMattina, Pfizer, research productivity
Big pharma’s policy of mergers and swingeing cuts is having a devastating effect on drug research, says a former Pfizer …
Pfizer looks to spin off animal health and nutrition
August 2, 2011Sales and Marketing Pfizer, Q2, animal health, divestment, nutrition
Pfizer looks set to spin-off or sell its animal health and nutrition business units in order to focus on human …
Digital Pharma: Pfizer’s Facebook page hacked
July 22, 2011Medical Communications Digital Pharma blog, Facebook, Pfizer
Pfizer has regained control of its corporate Facebook page after hackers temporarily defaced it earlier this week. A UK group …
Pfizer’s ageing blockbuster Lipitor wins $770m paediatric boost
July 11, 2011Sales and Marketing Lipitor, Pfizer, paediatric trials
Pfizer has been given more time to sell its anti-cholesterol treatment Lipitor exclusively in Europe as a quid pro quo …
Pfizer sharpens its pharma focus
July 8, 2011Sales and Marketing Pfizer, animal health, nutrition, pharma strategy
Pfizer has given its strongest signal yet that its animal health and nutrition arms do not have long to last …
Study claims cardiovascular risk to Pfizer’s Champix
July 6, 2011Research and Development, Sales and Marketing Champix, Chantix, Pfizer, smoking cessation
Pfizer has been drawn into a war of words over its smoking cessation drug Champix after a review of existing …
Pfizer re-acquires Rouses Point from Akrimax
July 5, 2011Manufacturing and Production Pfizer, pharma manufacturing news
Pfizer has decided to buy back a manufacturing facility in Rouses Point, New York, from current owner Akrimax Pharmaceuticals, and …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
